Microdeletions in 1q21 and 8q12.1 depict two additional molecular subgroups of Silver-Russell syndrome like phenotypes

[1]  J. Beilby,et al.  Further heterogeneity in Silver–Russell syndrome: PLAG1 deletion in association with a complex chromosomal rearrangement , 2021, American journal of medical genetics. Part A.

[2]  S. McKee,et al.  Whole-genome analysis as a diagnostic tool for patients referred for diagnosis of Silver-Russell syndrome: a real-world study , 2021, Journal of Medical Genetics.

[3]  I. Temple,et al.  Silver Russell syndrome in a  preterm girl with 8q12.1 deletion encompassing PLAG1. , 2021 .

[4]  T. Eggermann,et al.  One test for all: whole exome sequencing significantly improves the diagnostic yield in growth retarded patients referred for molecular testing for Silver–Russell syndrome , 2021, Orphanet Journal of Rare Diseases.

[5]  Yerai Vado,et al.  Novel Variant in PLAG1 in a Familial Case with Silver–Russell Syndrome Suspicion , 2020, Genes.

[6]  L. Dunkel,et al.  Rare CNVs provide novel insights into the molecular basis of GH and IGF-1 insensitivity , 2020, European journal of endocrinology.

[7]  V. Tasic,et al.  Need for a precise molecular diagnosis in Beckwith-Wiedemann and Silver-Russell syndrome: what has to be considered and why it is important , 2020, Journal of Molecular Medicine.

[8]  K. Yamazawa,et al.  Contribution of gene mutations to Silver-Russell syndrome phenotype: multigene sequencing analysis in 92 etiology-unknown patients , 2020, Clinical Epigenetics.

[9]  T. Eggermann,et al.  HMGA2 variants in Silver-Russell syndrome: homozygous and heterozygous occurrence. , 2020, The Journal of clinical endocrinology and metabolism.

[10]  T. Ogata,et al.  IGF2 Mutations: Report of Five Cases, Review of the Literature, and Comparison with H19/IGF2:IG-DMR Epimutations. , 2019, The Journal of clinical endocrinology and metabolism.

[11]  Z. Tümer,et al.  Structural and sequence variants in patients with Silver‐Russell syndrome or similar features—Curation of a disease database , 2018, Human mutation.

[12]  T. Yuen,et al.  Genetic disruption of the oncogenic HMGA2–PLAG1–IGF2 pathway causes fetal growth restriction , 2017, Genetics in Medicine.

[13]  M. Maghnie,et al.  Diagnosis and management of Silver–Russell syndrome: first international consensus statement , 2017, Nature Reviews Endocrinology.

[14]  S. Chantot-Bastaraud,et al.  A prospective study validating a clinical scoring system and demonstrating phenotypical-genotypical correlations in Silver-Russell syndrome , 2015, Journal of Medical Genetics.

[15]  A. Jauch,et al.  Molecular karyotyping as a relevant diagnostic tool in children with growth retardation with Silver-Russell features. , 2012, The Journal of pediatrics.

[16]  W. Robinson,et al.  An interstitial deletion of proximal 8q (q11–q13) in a girl with Silver‐russell syndrome‐like features , 1994, Clinical dysmorphology.